CONTRAINDICATIONS SECTION
History of a serious hypersensitivity reaction to sitagliptin, such as anaphylaxis or angioedema. [See Warnings and Precautions (5.4); Adverse Reactions (6.2).]
History of a serious hypersensitivity reaction to sitagliptin, such as anaphylaxis or angioedema. [See Warnings and Precautions (5.4); Adverse Reactions (6.2).]
SITAGLIPTIN/METFORMIN 50/850MG
| Class | Version | Type | Effective |
|---|---|---|---|
| METFORMIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| SITAGLIPTIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 82922-100-01 | 2024-07-30 | C162847 | 48780-1 | 1030e365-4cb4-111a-e063-dadaa90a10e2 | SITAGLIPTIN - METFORMIN |
| 82922-100-01 | 2024-01-30 | C162847 | 48780-1 | 1030e365-4cb4-111a-e063-dadaa90a10e2 | SITAGLIPTIN - METFORMIN |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 82922-100-01 | SITAGLIPTIN - METFORMIN | 28 in 1 BOTTLE, PLASTIC | TABLET | 28 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 82922-100 | 82922-100-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| METFORMIN | 9100L32L2N | ACTIB |
| SITAGLIPTIN | QFP0P1DV7Z | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f9519812-a5b1-1a19-e053-6294a90a471d | f9519812-a5b0-1a19-e053-6294a90a471d | 2023-04-14 | f9519812-a5b1-1a19-e053-6294a90a471d f9519812-a5b0-1a19-e053-6294a90a471d |
Adverse event summaries are temporarily unavailable. Other product information remains available.